Nefiracetam
Nefiracetam (DM9384), a modulator of GABAergic, cholinergic, and monoaminergic systems, is under Phase 2 clinical investigation. It has demonstrated efficacy in preclinical models, such as suppressing Ro 5-4864-induced convulsions in vivo, supporting research in neuroscience and cognitive disorders.
Product Specifications
CAS Number
77191-36-7
Product Name Alternative
DZL 221, DZL221, DZL-221, DM 9384, DM9384, DM-9384, GABAReceptor, Gamma-aminobutyric acid Receptor, GABAR, GABA Receptor, Inhibitor, Nefiracetam, inhibit, γ-Aminobutyric acid Receptor
Field of Research
Epigenetics & Chromatin, Metabolism Research, Neuroscience, Pharmacology & Drug Discovery, Signal Transduction
Purity
90.88% (May vary between batches)
Solubility
DMSO:70 mg/mL (284.21 mM) ; Ethanol:24.6 mg/mL (99.88 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (8.12 mM)
Smiles
N (C (CN1C (=O) CCC1) =O) C2=C (C) C=CC=C2C
Molecular Formula
C14H18N2O2
Molecular Weight
246.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC205844L3 10 µg
BubR1 (BUB1B) (NM_001211) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details KBH12945 1x 96 Well
GENLISA Human Major Histocompatibility Complex, Class II, DQ Beta 2 (HLA-DQB2) ELISA
Sign In for Pricing
View Details 
K2743302 1.0 µg DNA
ZSWIM7 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 425038-01 100 mg
3-Chloro-5- (trifluoromethyl) pyridine-2-carboxylic acid
Sign In for Pricing
View Details 425038-02 250 mg
3-Chloro-5- (trifluoromethyl) pyridine-2-carboxylic acid
Sign In for Pricing
View Details